EHNA hydrochloride
-
Catalog number2265-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameerythro-9-(2-Hydroxy-3-nonyl)adenine; (αR,βS)-rel-6-amino-β-hexyl-α-methyl-9H-purine-9-ethanol, monohydrochloride; NSC 263164
-
DescriptionA selective inhibitor of the cGMP-specific phosphodiesterase (PDE2) (IC₅₀s = 0.8 and 2 μM from human and porcine myocardium, respectively, 3.5 μM in rat hepatocyte, and 5.5 μM in human platelet). Also a reversible adenosine deaminase inhibitor (IC₅₀ = 1.2 μM in human red blood cells)
-
CAS Number58337-38-5
-
Structure AvailableYes
-
Peptide sequenceNo
-
Salt FormNo
-
Molecular FormulaC₁₄H₂₃N₅O ∙ HCl
-
Molecular Weight313.83
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>10 mg/ml) or H₂O (>10 mg/ml)
-
HandlingProtect from light and moisture
-
Tag LineA cGMP-specific phosphodiesterase (PDE2) inhibitor
-
Storage Condition-20°C
-
Shipping ConditionRT
-
Shelf Life24 months
-
MDL NumberMFCD00151066
-
PubChem CID11957547
-
SMILESCCCCCCC(C(C)O)N1C=NC2=C1N=CN=C2N.Cl
-
InChiInChI=1S/C14H23N5O.ClH/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19;/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17);1H/t10-,11+;/m1./s1
-
InChi KeyVVDXNJRUNJMYOZ-DHXVBOOMSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameEHNA hydrochloride
-
Alternative nameEHNA hydrochloride
-